Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.960
+0.020 (0.40%)
At close: Jul 3, 2025, 1:00 PM
5.08
+0.12 (2.42%)
After-hours: Jul 3, 2025, 4:46 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $53.70 million as of July 3, 2025. Its market cap has increased by 375.27% in one year.
Market Cap
53.70M
Enterprise Value
-70.54M
1-Year Change
375.27%
Ranking
Category
Stock Price
$4.96
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $53.70M, an increase of 55.67%. That is a compound annual growth rate of 4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 53.50M | -30.70% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.83B |
| Johnson & Johnson | 374.94B |
| AbbVie | 337.56B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 281.10B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 234.36B |
| AstraZeneca | 219.33B |